位置:首页 > 蛋白库 > PDRP1_ARATH
PDRP1_ARATH
ID   PDRP1_ARATH             Reviewed;         403 AA.
AC   O49562; B9DFD8; Q2V3G6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   03-AUG-2022, entry version 139.
DE   RecName: Full=Pyruvate, phosphate dikinase regulatory protein 1, chloroplastic;
DE            EC=2.7.11.32 {ECO:0000269|PubMed:21883547};
DE            EC=2.7.4.27 {ECO:0000269|PubMed:21883547};
DE   AltName: Full=Bifunctional dikinase regulatory protein 1;
DE            Short=AtRP1;
DE            Short=BFRP1;
DE   AltName: Full=Pyruvate, Pi dikinase regulatory protein 1;
DE            Short=PPDK RP1;
DE            Short=PPDK regulatory protein 1;
DE   Flags: Precursor;
GN   Name=RP1; OrderedLocusNames=At4g21210; ORFNames=F7J7.150;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G., Pohl T.,
RA   Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N., Harris B.,
RA   Ansorge W., Brandt P., Grivell L.A., Rieger M., Weichselgartner M.,
RA   de Simone V., Obermaier B., Mache R., Mueller M., Kreis M., Delseny M.,
RA   Puigdomenech P., Watson M., Schmidtheini T., Reichert B., Portetelle D.,
RA   Perez-Alonso M., Boutry M., Bancroft I., Vos P., Hoheisel J.,
RA   Zimmermann W., Wedler H., Ridley P., Langham S.-A., McCullagh B.,
RA   Bilham L., Robben J., van der Schueren J., Grymonprez B., Chuang Y.-J.,
RA   Vandenbussche F., Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R.,
RA   Defoor E., Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W., Mooijman P.,
RA   Klein Lankhorst R., Rose M., Hauf J., Koetter P., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Van den Daele H., De Keyser A., Buysshaert C.,
RA   Gielen J., Villarroel R., De Clercq R., van Montagu M., Rogers J.,
RA   Cronin A., Quail M.A., Bray-Allen S., Clark L., Doggett J., Hall S.,
RA   Kay M., Lennard N., McLay K., Mayes R., Pettett A., Rajandream M.A.,
RA   Lyne M., Benes V., Rechmann S., Borkova D., Bloecker H., Scharfe M.,
RA   Grimm M., Loehnert T.-H., Dose S., de Haan M., Maarse A.C., Schaefer M.,
RA   Mueller-Auer S., Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D.,
RA   Herzl A., Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R., Schnabl S.,
RA   Hiller R., Schmidt W., Lecharny A., Aubourg S., Chefdor F., Cooke R.,
RA   Berger C., Monfort A., Casacuberta E., Gibbons T., Weber N., Vandenbol M.,
RA   Bargues M., Terol J., Torres A., Perez-Perez A., Purnelle B., Bent E.,
RA   Johnson S., Tacon D., Jesse T., Heijnen L., Schwarz S., Scholler P.,
RA   Heber S., Francs P., Bielke C., Frishman D., Haase D., Lemcke K.,
RA   Mewes H.-W., Stocker S., Zaccaria P., Bevan M., Wilson R.K.,
RA   de la Bastide M., Habermann K., Parnell L., Dedhia N., Gnoj L., Schutz K.,
RA   Huang E., Spiegel L., Sekhon M., Murray J., Sheet P., Cordes M.,
RA   Abu-Threideh J., Stoneking T., Kalicki J., Graves T., Harmon G.,
RA   Edwards J., Latreille P., Courtney L., Cloud J., Abbott A., Scott K.,
RA   Johnson D., Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D., Du H.,
RA   Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C., Antonoiu B.,
RA   Zidanic M., Strong C., Sun H., Lamar B., Yordan C., Ma P., Zhong J.,
RA   Preston R., Vil D., Shekher M., Matero A., Shah R., Swaby I.K.,
RA   O'Shaughnessy A., Rodriguez M., Hoffman J., Till S., Granat S., Shohdy N.,
RA   Hasegawa A., Hameed A., Lodhi M., Johnson A., Chen E., Marra M.A.,
RA   Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana.";
RL   Nature 402:769-777(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=19423640; DOI=10.1093/dnares/dsp009;
RA   Iida K., Fukami-Kobayashi K., Toyoda A., Sakaki Y., Kobayashi M., Seki M.,
RA   Shinozaki K.;
RT   "Analysis of multiple occurrences of alternative splicing events in
RT   Arabidopsis thaliana using novel sequenced full-length cDNAs.";
RL   DNA Res. 16:155-164(2009).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17996018; DOI=10.1111/j.1365-313x.2007.03366.x;
RA   Chastain C.J., Xu W., Parsley K., Sarath G., Hibberd J.M., Chollet R.;
RT   "The pyruvate, orthophosphate dikinase regulatory proteins of Arabidopsis
RT   possess a novel, unprecedented Ser/Thr protein kinase primary structure.";
RL   Plant J. 53:854-863(2008).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH PPDK1, AND MUTAGENESIS OF
RP   SER-122; ASP-123; TYR-238; ASP-252; GLY-269; SER-271; ARG-272; LYS-275;
RP   PRO-277; SER-279; ALA-283; ASN-291; PRO-293; ARG-326; ARG-329; TYR-343;
RP   GLU-352; GLU-377; GLU-378; THR-379 AND ALA-380.
RX   PubMed=21883547; DOI=10.1111/j.1365-313x.2011.04759.x;
RA   Astley H.M., Parsley K., Aubry S., Chastain C.J., Burnell J.N., Webb M.E.,
RA   Hibberd J.M.;
RT   "The pyruvate, orthophosphate dikinase regulatory proteins of Arabidopsis
RT   are both bifunctional and interact with the catalytic and nucleotide-
RT   binding domains of pyruvate, orthophosphate dikinase.";
RL   Plant J. 68:1070-1080(2011).
CC   -!- FUNCTION: Bifunctional serine/threonine kinase and phosphorylase
CC       involved in the dark/light-mediated regulation of PPDK by catalyzing
CC       its phosphorylation/dephosphorylation. Dark/light-induced changes in
CC       stromal concentrations of the competing ADP and Pi substrates govern
CC       the direction of the reaction. In the dark, phosphorylates the
CC       catalytic intermediate of PPDK (PPDK-HisP), inactivating it. Light
CC       exposure induces the phosphorolysis reaction that reactivates PPDK.
CC       Unlike the kinase function which can utilize either Thr or Ser as
CC       target, the phosphorylase function has a strict substrate requirement
CC       for threonyl phosphate. {ECO:0000269|PubMed:17996018,
CC       ECO:0000269|PubMed:21883547}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ADP + N(tele)-phospho-L-histidyl/L-threonyl-[pyruvate,
CC         phosphate dikinase] = AMP + H(+) + N(tele)-phospho-L-histidyl/O-
CC         phospho-L-threonyl-[pyruvate, phosphate dikinase];
CC         Xref=Rhea:RHEA:43692, Rhea:RHEA-COMP:10650, Rhea:RHEA-COMP:10651,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:61977,
CC         ChEBI:CHEBI:83586, ChEBI:CHEBI:456215, ChEBI:CHEBI:456216;
CC         EC=2.7.11.32; Evidence={ECO:0000269|PubMed:21883547};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + N(tele)-phospho-L-histidyl/O-phospho-L-threonyl-
CC         [pyruvate, phosphate dikinase] + phosphate = diphosphate + N(tele)-
CC         phospho-L-histidyl/L-threonyl-[pyruvate, phosphate dikinase];
CC         Xref=Rhea:RHEA:43696, Rhea:RHEA-COMP:10650, Rhea:RHEA-COMP:10651,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:61977, ChEBI:CHEBI:83586; EC=2.7.4.27;
CC         Evidence={ECO:0000269|PubMed:21883547};
CC   -!- ACTIVITY REGULATION: Regulated by light/dark exposure.
CC   -!- SUBUNIT: Interacts with PPDK1. {ECO:0000269|PubMed:21883547}.
CC   -!- SUBCELLULAR LOCATION: Plastid, chloroplast stroma
CC       {ECO:0000269|PubMed:17996018}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O49562-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O49562-2; Sequence=VSP_034504;
CC   -!- TISSUE SPECIFICITY: Expressed in green tissues.
CC       {ECO:0000269|PubMed:17996018}.
CC   -!- MISCELLANEOUS: The initial 51 amino acids are sufficient to act as a
CC       chloroplast transit peptide and the removal of the next 35 amino acids
CC       reduces the strength of interaction with PPDK significantly, which
CC       suggested that these residues are important for binding RP1 and may not
CC       be part of the transit peptide (PubMed:21883547).
CC   -!- SIMILARITY: Belongs to the pyruvate, phosphate/water dikinase
CC       regulatory protein family. PDRP subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL021960; CAA17540.1; -; Genomic_DNA.
DR   EMBL; AL161554; CAB79121.1; -; Genomic_DNA.
DR   EMBL; CP002687; AEE84423.1; -; Genomic_DNA.
DR   EMBL; CP002687; AEE84424.1; -; Genomic_DNA.
DR   EMBL; AK316730; BAH19455.1; -; mRNA.
DR   PIR; T04952; T04952.
DR   RefSeq; NP_001031686.1; NM_001036609.1. [O49562-2]
DR   RefSeq; NP_193853.1; NM_118240.4. [O49562-1]
DR   AlphaFoldDB; O49562; -.
DR   SMR; O49562; -.
DR   IntAct; O49562; 1.
DR   STRING; 3702.AT4G21210.1; -.
DR   PaxDb; O49562; -.
DR   PRIDE; O49562; -.
DR   ProteomicsDB; 251349; -. [O49562-1]
DR   EnsemblPlants; AT4G21210.1; AT4G21210.1; AT4G21210. [O49562-1]
DR   EnsemblPlants; AT4G21210.2; AT4G21210.2; AT4G21210. [O49562-2]
DR   GeneID; 827869; -.
DR   Gramene; AT4G21210.1; AT4G21210.1; AT4G21210. [O49562-1]
DR   Gramene; AT4G21210.2; AT4G21210.2; AT4G21210. [O49562-2]
DR   KEGG; ath:AT4G21210; -.
DR   Araport; AT4G21210; -.
DR   TAIR; locus:2127413; AT4G21210.
DR   eggNOG; ENOG502SAAN; Eukaryota.
DR   HOGENOM; CLU_046206_0_0_1; -.
DR   InParanoid; O49562; -.
DR   OMA; YAQCEFE; -.
DR   OrthoDB; 1388649at2759; -.
DR   PhylomeDB; O49562; -.
DR   BRENDA; 2.7.11.32; 399.
DR   BRENDA; 2.7.4.27; 399.
DR   PRO; PR:O49562; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; O49562; baseline and differential.
DR   Genevisible; O49562; AT.
DR   GO; GO:0009507; C:chloroplast; IDA:TAIR.
DR   GO; GO:0009570; C:chloroplast stroma; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:TAIR.
DR   GO; GO:0016776; F:phosphotransferase activity, phosphate group as acceptor; IEA:InterPro.
DR   GO; GO:0004672; F:protein kinase activity; IDA:TAIR.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   HAMAP; MF_00921; PDRP; 1.
DR   InterPro; IPR005177; Kinase-pyrophosphorylase.
DR   InterPro; IPR026565; PPDK_reg.
DR   InterPro; IPR017409; Pyrv_Pi_dikinase_reg_chlpt.
DR   PANTHER; PTHR31756; PTHR31756; 1.
DR   Pfam; PF03618; Kinase-PPPase; 1.
DR   PIRSF; PIRSF038149; Pyruvate_Pi_dikinase_regulator; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chloroplast; Kinase; Nucleotide-binding; Plastid;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Transit peptide.
FT   TRANSIT         1..86
FT                   /note="Chloroplast"
FT                   /evidence="ECO:0000255"
FT   CHAIN           87..403
FT                   /note="Pyruvate, phosphate dikinase regulatory protein 1,
FT                   chloroplastic"
FT                   /id="PRO_0000196751"
FT   REGION          1..108
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        12..38
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        51..108
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         269..276
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         297..323
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_034504"
FT   MUTAGEN         122
FT                   /note="S->A: No effect on phosphotransferase and kinase
FT                   activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         123
FT                   /note="D->A: No effect on phosphotransferase and kinase
FT                   activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         238
FT                   /note="Y->F: No effect on phosphotransferase and kinase
FT                   activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         252
FT                   /note="D->N: No effect on the interaction with PPDK, but
FT                   loss of phosphotransferase activity and partially reduced
FT                   kinase activity."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         269
FT                   /note="G->A: No effect on the interaction with PPDK, but
FT                   loss of phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         271
FT                   /note="S->A: No effect on the interaction with PPDK, but
FT                   loss of phosphotransferase activity and partially reduced
FT                   kinase activity."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         272
FT                   /note="R->M: Weak interaction with PPDK, and loss of
FT                   phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         275
FT                   /note="K->M: Weak interaction with PPDK, and loss of
FT                   phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         277
FT                   /note="P->A: Weak interaction with PPDK, and loss of
FT                   phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         279
FT                   /note="S->A: No effect on phosphotransferase and kinase
FT                   activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         283
FT                   /note="A->T: No effect on the interaction with PPDK, but
FT                   loss of phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         291
FT                   /note="N->A: No effect on the interaction with PPDK, but
FT                   loss of phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         293
FT                   /note="P->A: No effect on the interaction with PPDK, but
FT                   reduced phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         326
FT                   /note="R->M: Weak interaction with PPDK, and loss of
FT                   phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         329
FT                   /note="R->M: No effect on the interaction with PPDK, but
FT                   loss of phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         343
FT                   /note="Y->F: Weak effect on the interaction with PPDK, but
FT                   loss of phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         352
FT                   /note="E->Q: Weak interaction with PPDK, and loss of
FT                   phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         377
FT                   /note="E->Q: Weak interaction with PPDK, and loss of
FT                   phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         378
FT                   /note="E->Q: No effect on phosphotransferase and kinase
FT                   activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         379
FT                   /note="T->V: No effect on phosphotransferase and kinase
FT                   activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
FT   MUTAGEN         380
FT                   /note="A->T: No effect on the interaction with PPDK, but
FT                   loss of phosphotransferase and kinase activities."
FT                   /evidence="ECO:0000269|PubMed:21883547"
SQ   SEQUENCE   403 AA;  43684 MW;  125AF179D5EA6564 CRC64;
     MALLSAMKLQ GRPPPISSNL NPNSKPAGSD SVSLNASEPG SERKPRKFSS QLNRWNRART
     LRSGAKLDST ITNGSNNTTG PMRPIESSSR TDVSTLDSDV SSSSNGVSEA DMTAAKSIYI
     VSDGTGWTAE HAVNAALGQF DYCLVDRGCP VNTHLFSGIE DGEKLMEIIK QAAREGAMVI
     YTLADPSMAE ATMRACKLWK IPSLDILGPI TESISSHLGT NPSGLSRGIT NSSLNEDYFK
     RIEAIEFTIK HDDGALPENL EKADIVLVGV SRTGKTPLST YLAQKGYKVS NVPIVNGVDL
     PKTLFEIDPR KVFGLMINPL VLQGIREARA KSLGLGSSFK TKYSELGSVK EELELAKKIF
     AENPTWPVIE VTESAIEETA AVVLRLYDER QSNRAMPRIS KSY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024